The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
08/11/2016 | Managing Intellectual Property Blog
1 min
June 05, 2025
June 03, 2025
May 28, 2025
June 11, 2025
June 11, 2025
June 06, 2025